1. Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials. Issue 1 (25th March 2019) Authors: Lancaster, Lisa; Crestani, Bruno; Hernandez, Paul; Inoue, Yoshikazu; Wachtlin, Daniel; Loaiza, Lazaro; Quaresma, Manuel; Stowasser, Susanne; Richeldi, Luca Journal: BMJ open respiratory research Issue: Volume 6:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). Issue 1 (30th December 2021) Authors: Corte, Tamera J; Lancaster, Lisa; Swigris, Jeffrey J; Maher, Toby M; Goldin, Jonathan G; Palmer, Scott M; Suda, Takafumi; Ogura, Takashi; Minnich, Anne; Zhan, Xiaojiang; Tirucherai, Giridhar S; Elpers, Brandon; Xiao, Hong; Watanabe, Hideaki; Smith, R Adam; Charles, Edgar D; Fischer, Aryeh Journal: BMJ open respiratory research Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts. Issue 1 (15th January 2021) Authors: Machahua, Carlos; Guler, Sabina A.; Horn, Michael P.; Planas-Cerezales, Lurdes; Montes-Worboys, Ana; Geiser, Thomas K.; Molina-Molina, Maria; Funke-Chambour, Manuela Journal: BMJ open respiratory research Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. Issue 1 (20th January 2022) Authors: Popmihajlov, Zoran; Sutherland, Donna J; Horan, Gerald S; Ghosh, Atalanta; Lynch, David A; Noble, Paul W; Richeldi, Luca; Reiss, Theodore F; Greenberg, Steven Journal: BMJ open respiratory research Issue: Volume 9:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. Issue 1 (17th May 2020) Authors: Arai, Toru; Kida, Hiroshi; Ogata, Yoshitaka; Marumo, Satoshi; Matsuoka, Hiroto; Gohma, Iwao; Yamamoto, Suguru; Mori, Masahide; Sugimoto, Chikatoshi; Tachibana, Kazunobu; Akira, Masanori; Inoue, Yoshikazu Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. Issue 1 (17th May 2020) Authors: Arai, Toru; Kida, Hiroshi; Ogata, Yoshitaka; Marumo, Satoshi; Matsuoka, Hiroto; Gohma, Iwao; Yamamoto, Suguru; Mori, Masahide; Sugimoto, Chikatoshi; Tachibana, Kazunobu; Akira, Masanori; Inoue, Yoshikazu Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. Issue 1 (17th May 2020) Authors: Arai, Toru; Kida, Hiroshi; Ogata, Yoshitaka; Marumo, Satoshi; Matsuoka, Hiroto; Gohma, Iwao; Yamamoto, Suguru; Mori, Masahide; Sugimoto, Chikatoshi; Tachibana, Kazunobu; Akira, Masanori; Inoue, Yoshikazu Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. Issue 1 (5th July 2020) Authors: Snyder, Laurie D; Mosher, Christopher; Holtze, Colin H; Lancaster, Lisa H; Flaherty, Kevin R; Noth, Imre; Neely, Megan L; Hellkamp, Anne S; Bender, Shaun; Conoscenti, Craig S; de Andrade, Joao A; Whelan, Timothy PM Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. Issue 1 (17th May 2020) Authors: Arai, Toru; Kida, Hiroshi; Ogata, Yoshitaka; Marumo, Satoshi; Matsuoka, Hiroto; Gohma, Iwao; Yamamoto, Suguru; Mori, Masahide; Sugimoto, Chikatoshi; Tachibana, Kazunobu; Akira, Masanori; Inoue, Yoshikazu Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. Issue 1 (5th July 2020) Authors: Snyder, Laurie D; Mosher, Christopher; Holtze, Colin H; Lancaster, Lisa H; Flaherty, Kevin R; Noth, Imre; Neely, Megan L; Hellkamp, Anne S; Bender, Shaun; Conoscenti, Craig S; de Andrade, Joao A; Whelan, Timothy PM Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗